Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male Volunteers

NCT01594515 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1015550
DRUG: BI 1015550
DRUG: BI 1015550
DRUG: BI 1015550
DRUG: BI 1015550
DRUG: Placebo
DRUG: BI 101550
DRUG: BI 1015550
DRUG: BI 1015550
DRUG: BI 1015550

Sponsor

Boehringer Ingelheim